Clinical Trial Update: Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether zinc sulfate has an antifibrotic effect in chronic hepatitis C patients receiving direct-acting antiviral therapy; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Zinc sulfate (Zinc sulfate)

Snippet

Sponsor: Tanta University | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED